LactaLogics has filed a notice of an exempt offering of securities to raise $24,999,999.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, LactaLogics is raising up to $24,999,999.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Glenn Snow played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About LactaLogics
In 2012 we discovered that almost all premature infants in hospital NICUs do not receive the lifesaving benefits of human milk. We set out to find a solution, utilizing innovative technology and holistic donor care, connecting moms with excess milk to infants in need. Newborns thrive best on breast milk. An exclusive human milk diet is proven to reduce infection and mortality while promoting healthy growth, but the first year of life doesn’t always go as planned. Breast milk isn’t always available when complications arise, like premature birth. LactaLogics is changing this. By utilizing the latest technology and being committed to holistic donor care, we are moving infant nutrition forward. Hospitals, babies, and their parents will soon have access to 100% human milk-based products that are safe, affordable, and easy to administer. All products are in the development stage and are not yet commercially available for sale or distribution.
To learn more about LactaLogics, visit http://lactalogics.com/
Contact:
Glenn Snow, Chief Executive Officer
772-202-0284
https://www.linkedin.com/in/glenn-snow-lactalogics/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.